Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ALEC — Alector, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$179,235
+$105,005 QoQ
Shares Held
89,172
+158.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ALEC ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ALEC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $179,235 89,172
2026-03-31 $74,230 34,526
2025-12-31 $140,567 90,108
2025-09-30 $155,177 52,425
2025-06-30 $70,840 50,601
2025-03-31 $48,504 39,435
2024-12-31 $71,755 37,966
2024-09-30 $117,957 25,313
2024-06-30 $118,465 26,094
2024-03-31 $131,711 21,879
2023-12-31 $133,209 16,693
2023-09-30 $303,756 46,876
2023-06-30 $331,625 55,179
2023-03-31 $329,970 53,307
2022-12-31 $18 2
2022-09-30 $34,858 3,685
2022-06-30 $71,992 7,086
2022-03-31 $955,262 67,036
2021-12-31 $1,751,737 84,830
2021-09-30 $988,629 43,323
2021-06-30 $60,760 2,917
2021-03-31 $115,985 5,759
2020-12-31 $1,220,853 80,691
2020-09-30 $208,380 19,780
2020-06-30 $584,823 23,929
2020-03-31 $1,433,200 59,395